Your browser doesn't support javascript.
loading
Initiation of immunotherapy with activated natural killer cells and anti-GD2 antibody dinutuximab prior to resection of primary neuroblastoma prolongs survival in mice.
Zobel, Michael John; Zamora, Abigail K; Wu, Hong-Wei; Sun, Jianping; Lascano, Danny; Malvar, Jemily; Wang, Larry; Sheard, Michael A; Seeger, Robert C; Kim, Eugene S.
Afiliação
  • Zobel MJ; Division of Pediatric Surgery, Department of Surgery, Children's Hospital Los Angeles, Los Angeles, California, USA.
  • Zamora AK; Division of Pediatric Surgery, Department of Surgery, Children's Hospital Los Angeles, Los Angeles, California, USA.
  • Wu HW; Division of Hematology, Oncology, Blood and Marrow Transplantation, Department of Pediatrics, Children's Hospital Los Angeles, Los Angeles, California, USA.
  • Sun J; Division of Hematology, Oncology, Blood and Marrow Transplantation, Department of Pediatrics, Children's Hospital Los Angeles, Los Angeles, California, USA.
  • Lascano D; Division of Pediatric Surgery, Department of Surgery, Children's Hospital Los Angeles, Los Angeles, California, USA.
  • Malvar J; Division of Hematology, Oncology, Blood and Marrow Transplantation, Department of Pediatrics, Children's Hospital Los Angeles, Los Angeles, California, USA.
  • Wang L; Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, Los Angeles, California, USA.
  • Sheard MA; Division of Hematology, Oncology, Blood and Marrow Transplantation, Department of Pediatrics, Children's Hospital Los Angeles, Los Angeles, California, USA.
  • Seeger RC; Division of Hematology, Oncology, Blood and Marrow Transplantation, Department of Pediatrics, Children's Hospital Los Angeles, Los Angeles, California, USA.
  • Kim ES; Division of Pediatric Surgery, Department of Surgery, Children's Hospital Los Angeles, Los Angeles, California, USA eugeneskim@chla.usc.edu.
J Immunother Cancer ; 8(2)2020 12.
Article em En | MEDLINE | ID: mdl-33428582

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células Matadoras Naturais / Imunoterapia / Anticorpos Monoclonais / Neuroblastoma Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células Matadoras Naturais / Imunoterapia / Anticorpos Monoclonais / Neuroblastoma Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article